Moderna, Inc.

Historical 13F Holders

Symbol
MRNA
CUSIP
60770K107
All holders as of
Q1 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q1 790 270 M $13.7 B
2025 Q4 755 273 M $8.06 B
2025 Q3 732 277 M $7.16 B
2025 Q2 755 303 M $8.35 B
2025 Q1 771 282 M $8.00 B
2024 Q4 844 277 M $11.5 B
2024 Q3 891 265 M $17.6 B
2024 Q2 1,064 269 M $32.0 B
2024 Q1 1,005 276 M $29.4 B
2023 Q4 986 269 M $26.8 B
2023 Q3 986 247 M $25.9 B
2023 Q2 1,052 249 M $30.2 B
2023 Q1 1,111 273 M $38.5 B
2022 Q4 1,174 263 M $47.6 B
2022 Q3 1,008 248 M $29.3 B
2022 Q2 1,130 245 M $35.0 B
2022 Q1 1,118 251 M $43.3 B
2021 Q4 1,209 250 M $63.4 B
2021 Q3 1,242 243 M $93.5 B
2021 Q2 995 229 M $53.9 B
2021 Q1 857 210 M $27.4 B
2020 Q4 805 201 M $21.1 B
2020 Q3 626 206 M $14.5 B
2020 Q2 542 220 M $14.1 B
2020 Q1 334 196 M $5.88 B
2019 Q4 177 177 M $3.45 B
2019 Q3 151 169 M $2.69 B
2019 Q2 161 144 M $2.10 B
2019 Q1 115 138 M $2.80 B
2018 Q4 83 134 M $2.02 B